Aurinia Pharmaceuticals
AUPH
AUPH
183 hedge funds and large institutions have $528M invested in Aurinia Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 45 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 39
40% less capital invested
Capital invested by funds: $884M → $528M (-$356M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
183
Holding in Top 10
–
Calls
$96.8M
Puts
$46.3M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$19M | |
| 3 | +$13.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.2M |
| 5 |
Millennium Management
New York
|
+$11.2M |
Top Sellers
| 1 | -$33.2M | |
| 2 | -$26.4M | |
| 3 | -$22.7M | |
| 4 |
MAM
Melqart Asset Management
London,
United Kingdom
|
-$21M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$20.1M |